TRAZAFY Trademark

Trademark Overview

On Tuesday, May 22, 2018, a trademark application was filed for TRAZAFY with the United States Patent and Trademark Office. The USPTO has given the TRAZAFY trademark a serial number of 87931831. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 5, 2021. This trademark is owned by Pfizer Inc.. The TRAZAFY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer
trazafy

General Information

Serial Number87931831
Word MarkTRAZAFY
Filing DateTuesday, May 22, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 5, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2018

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 31, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, July 6, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 5, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 13, 2020EXTENSION 4 GRANTED
Friday, November 13, 2020EXTENSION 4 FILED
Friday, November 13, 2020TEAS EXTENSION RECEIVED
Thursday, May 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 26, 2020EXTENSION 3 GRANTED
Tuesday, May 26, 2020EXTENSION 3 FILED
Tuesday, May 26, 2020TEAS EXTENSION RECEIVED
Tuesday, November 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 15, 2019EXTENSION 2 GRANTED
Friday, November 15, 2019EXTENSION 2 FILED
Friday, November 15, 2019TEAS EXTENSION RECEIVED
Friday, May 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2019EXTENSION 1 GRANTED
Wednesday, May 22, 2019EXTENSION 1 FILED
Wednesday, May 22, 2019TEAS EXTENSION RECEIVED
Tuesday, December 4, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 31, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 29, 2018ASSIGNED TO EXAMINER
Thursday, May 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 25, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

trazafy cancer treatment prevention products pharmaceutical